CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Other disposition | −6,881.24 | $36.50 | $251K | 55,403 |
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company | −55,403 | $36.50 | $2.0M | 0 |
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −6,250 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −11,200 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −6,500 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −14,600 | 0 | ||
| 2026-11-17 | RIKER LAUREN Senior Vice President, Finance | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2026-10-08 | RIKER LAUREN Senior Vice President, Finance | Exercise or conversion 10b5-1 | +6,000 | $32.35 | $194K | 68,284.24 |
| 2026-10-08 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −6,000 | $36.32 | $218K | 62,284.24 |
| 2026-10-08 | RIKER LAUREN Senior Vice President, Finance | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −6,000 | 0 | ||
| 2026-06-11 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −6,115 | $23.50 | $144K | 62,284.24 |
| 2026-06-03 | RIKER LAUREN Senior Vice President, Finance | Shares withheld for taxes | −3,187 | $22.32 | $71K | 68,399.24 |
| 2026-02-11 | RIKER LAUREN Senior Vice President, Finance | Grant or award | +19,273 | 71,586.24 | ||
| 2026-02-02 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −4,000 | $20.81 | $83K | 52,313.24 |
Page 1 of 2 · 31 trades